![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Anon. 2004. Point-of-care testing (near-patient testing). Guidance on the involvement of the clinical laboratory. London: Institute of Biomedical Science.
- Anon. 2008. False-positive oral fluid rapid HIV tests – New York City, 2005–2008. MMWR. Morbidity and Mortality Weekly Report 57:1–5.
- Brenwald NP, Baker N, Oppenheim B. 2010. Feasibility study of a real-time PCR test for methicillin-resistant Staphylococcus aureus in a point-of-care setting. Journal of Hospital Infection 74:245–249.
- Centers for Disease Control and Prevention. 2005. Good laboratory practices for waived test sites. Survey findings from testing sites holding a certificate of waiver under the Clinical Laboratory Improvement Amendments of 1988 and recommendations for promoting quality testing. MMWR, Morbidity and Mortality Weekly Report 54:RR-13.
- Cramb R. 2004. Guidelines on point-of-care testing. London: The Royal College of Pathologists.
- Daniels J, Gray J, Pattison H, Roberts T, Edwards E, Milner P . 2009. Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness. Health Technology Assessment 13:1–154.
- Device Bulletin. 2003. Management and use of IVD point-of-care test devices. MDA DB2002(03). London: Medical Devices Agency.
- Griffiths MW. 1997. Rapid microbiological methods with hazard analysis critical control point. Journal of AOAC International 80:1143–1150.
- Haglund S, Transö B, Persson LG, Zafirova T, Grodzinsky E. 2009. Fast laboratory test results alone cannot deliver the benefits of near patient testing: a follow-up study after 3 years of extended laboratory service at a primary health care centre. Journal of Evaluation in Clinical Practice 15:227–33.
- Harbarth S, Masuet-Aumatell C, Schrenzel J, Francois P, Akakpo C, Renzi G . 2006. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Critical Care 10:R25.
- Hatchette TF, Bastien N, Berry J, Booth TF, Chernesky M, Couillard M . 2009. The limitations of point-of-care testing for pandemic influenza: what clinicians and public health professionals need to know. Canadian Journal of Public Health 100:204–7.
- Information Centre for Health and Social Care. 2005. Sickness absence rates of NHS staff in 2004. London: Department of Health.
- Kiechle FL, Holland CA. 2009. Point-of-care testing and molecular diagnostics: miniaturization required. Clinics in Laboratory Medicine 29:555–60.
- Kim JY, Lewandrowski K. 2009. Point-of-care testing informatics. Clinics in Laboratory Medicine 29:449–61.
- Lee-Lewandrowski E, Lewandrowski K. 2009. Perspectives on cost and outcomes for point-of-care testing. Clinics in Laboratory Medicine 29:479–89.
- Martin CL. 2008. Quality control issues in point-of-care testing. Clinical Biochemist Reviews 29:S79–S82.
- NHS Institute for Innovation and Improvement. Workforce: Acute Trusts. Available at: www.productivity.nhs.uk (Accessed January 2010).
- Price CP. 2001. Point-of-care testing. Impact on medical outcomes. Clinics in Laboratory Medicine 21:285–303.
- Robertson BH, Nicholson JK. 2005. New microbiology tools for public health and their implications. Annual Review of Public Health 26: 281–302.
- US Food and Drug Administration. CLIA categorization criteria. Available at: www.fda.gov/cdrh/clia/categorization.html (Accessed January 2010).